How to find quality and profitability in financial companies
Julian Cane, manager of the CT UK Capital & Income Trust, picks three financial companies as he shares where he'd put his money


The CT UK Capital & Income Investment Trust assesses investments against the yardsticks of quality, management and valuation. This provides a systematic way of analysing companies and their shares’ appeal.
Attributes relating to quality that score well include high and sustainable return on equity, strong market position, good margins and growth. We look to management to be efficient operators, skilled allocators of capital and well-aligned with shareholders.
Valuation is not just assessing how “cheap” a share is on an absolute basis or relative to other opportunities but is also a comparison of our estimate of a company’s worth relative to its share price.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Importantly, it is forward-looking and based on tangible drivers of value such as cash flow, dividends and asset value. Here are three stocks that stack up well on this basis. They are all financial companies that provide capital to others, but they are very different from high-street banks.
Finding value in private equity
Intermediate Capital Group (LSE: ICG) is a global leader in alternative asset management, investing money for itself and on behalf of its clients in private companies. Over many years and a growing number of strategies, ICG has generated impressive returns; this in turn has attracted more investors to its funds, which have grown strongly.
ICG has a well-regarded management team and in our opinion, the valuation does not reflect the considerable growth opportunities within its existing strategies, in new strategies and expanding geographies.
OSB Group (LSE: OSB) is a leading mortgage lender operating in specialist areas – particularly for the professional buy-to-let landlord – which are not well served by the main UK banks. Specialist skills and systems are often necessary in order to be able to operate in these particular areas, which are also arguably too small to be of much interest to larger banks.
This provides the opportunity for OSB to lend at attractive risk-adjusted prices, which, with its efficient cost base, then translate into profitable returns. The death of buy-to-let has frequently been predicted in the press, but this is much less relevant for professional landlords with multiple properties, and OSB has continued to grow.
A remarkable record
Burford Capital (Aim: BUR) is the leading global finance and asset management firm focused on law, mostly providing capital for litigation. Through its skilful due diligence, it has a remarkable record in backing successful cases. Since its inception through to 30 September 2024, of the cases it has backed 76% have settled in their clients’ favour, 17% have gone to adjudication and won, leaving only 7% that have lost at adjudication.
This translates into very attractive returns, with an average 84% return on invested capital and 26% internal rate of return – figures that would be the envy of any investor and serve as a powerful incentive to invest in the Burford funds.
The founders have very significant shareholdings and have shown great skill and energy in developing the business, which they still lead. The valuation is not straightforward as, like ICG, it is both a financier and asset manager. Still, the stock trades on a prospective price/earnings (p/e) ratio of less than ten.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Julian Cane is manager of the CT UK Capital & Income Investment Trust and a Director and Fund Manager in Columbia Threadneedle's UK Equities team. He joined Columbia Threadneedle through the acquisition of BMO GAM (EMEA) in 2021, having previously been with BMO (and its predecessor companies) since 1993. He became the Fund Manager for the F&C Income Growth Investment Trust in 1997, which subsequently became the CT UK Capital and Income Investment Trust. Julian has an MA degree in Economics from the University of Cambridge.
-
Barclays begins paying up to £100 compensation to customers after banking outage
Barclays will pay up to £7.5 million in compensation to customers after its banking services were disrupted by an IT outage
By Daniel Hilton Published
-
Review: Shangri-La Paris – an ode to the world’s best food
Natasha Langan enjoys fine French and Chinese cuisine at the Shangri-La Paris
By Natasha Langan Published
-
The star small and mid-cap stocks income investors have overlooked
Opinion Thomas Moore, senior investment director, Aberdeen, highlights three company stocks as he shares where he would put his money
By Thomas Moore Published
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge Published
-
Chemring Group: an explosive investment opportunity in defence
European states are raising their military spending, and Chemring Group looks well placed to profit
By Rupert Hargreaves Published
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field Published
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward Published
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves Published
-
Three top-notch Taiwanese companies cashing in on the advent of AI
Opinion Eric Chan, investment director and co-manager of the Aberdeen Asian Income Fund, highlights three potential Taiwanese winners in the technology industry
By Eric Chan Published
-
Find tomorrow’s Asian giants while they are still smaller companies
Opinion Nitin Bajaj, portfolio manager of the Fidelity Asian Values trust, picks three Asian companies to invest in.
By Nitin Bajaj Published